Merck Withdraws Bid For EU Regulatory OK Of Asthma Medicine – NASDAQ

Merck Withdraws Bid For EU Regulatory OK Of Asthma Medicine
NASDAQ
(MRK) has withdrawn its application for European regulatory approval of an asthma treatment, citing outstanding questions by regulators.

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *